2017 Regular Session
|At the request of:|
|Chief Sponsors:||Representative Post, Buehler|
|Regular Sponsors:||Representative Barreto, Parrish (Presession Filed)|
|Bill Title:||Relating to pseudoephedrine; prescribing an effective date.|
|Catchline/Summary:||Deletes requirement that pseudoephedrine be classified as Schedule III controlled substance.
Directs State Board of Pharmacy to adopt rules for dispensing pseudoephedrine. Requires rules to be consistent with provisions of federal Controlled Substances Act that are related to dispensing of pseudoephedrine and federal regulations that implement those provisions. Punishes violation of rules by five years' imprisonment, $125,000 fine, or both. Becomes operative January 1, 2018. Takes effect on 91st day following adjournment sine die.
|Fiscal Impact:||May Have Fiscal Impact, But No Statement Yet Issued|
|Revenue Impact:||May Have Revenue Impact, But No Statement Yet Issued|
|Measure Analysis:||Staff Measure Summary / Impact Statements|
|Current Location:||In House Committee|
|Current Committee:||House Committee On Health Care|